Drug Addiction-Pipeline Insights - 2016

April 14th 2016 Mumbai, India: Bharatbook.com announces a report on “ Drug Addiction-Pipeline Insights – 2016 ”. The Report also provides Drug Addiction related therapeutic assessments by molecule type, route of administration, monotherapy and combination products.

Summary

Drug Addiction- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Drug Addiction. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Drug Addiction Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

Drug Addiction- Pipeline Insights, 2015 Report covers the Drug Addiction pipeline molecules at various stages of development like Pre-registration phase, clinical phases (Phase III, Phase II & Phase I), pre-clinical and discovery phases. The Report also provides Drug Addiction related therapeutic assessments by molecule type, route of administration, monotherapy and combination products. The Report also highlights the discontinued and inactive projects in pipeline for Drug Addiction.

Scope

- DelveInsight’s report provides a Drug Addiction Landscape across the globe

- The report provides drug profiles which includes product description, MOA, licensors & collaborators, technology, development partner and chemical information

- Coverage of the Drug Addiction pipeline on the basis of target, MOA, route of administration, technology involved and molecule type

- The report reviews key players involved in the therapeutics development for Drug Addiction and also provide company profiling

- Pipeline products coverage based on various stages of development from NDA filings to discovery.

- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

Reasons to buy

- Complete...